CVE-2025-1055

K7 Security Anti-Malware: IOCTL in K7RKScan.sys Allows Arbitrary Termination of High-Privilege and System Processes by a Low-Privilege User

Description

A vulnerability in the K7RKScan.sys driver, part of the K7 Security Anti-Malware suite, allows a local low-privilege user to send crafted IOCTL requests to terminate a wide range of processes running with administrative or system-level privileges, with the exception of those inherently protected by the operating system. This flaw stems from missing access control in the driver's IOCTL handler, enabling unprivileged users to perform privileged actions in kernel space. Successful exploitation can lead to denial of service by disrupting critical services or privileged applications.

Category

5.6
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.01%
Affected: K7 Security K7 Security Anti-Malware
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-1055?
CVE-2025-1055 has been scored as a medium severity vulnerability.
How to fix CVE-2025-1055?
To fix CVE-2025-1055, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-1055 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-1055 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-1055?
CVE-2025-1055 affects K7 Security K7 Security Anti-Malware.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.